Clinical spectrum of Niemann‐Pick disease type C

Analysis of the neurologic symptomatology in 22 patients with Niemann-Pick disease type C revealed 3 phenotypes: (1) an early-onset, rapidly progressive form associated with severe hepatic dysfunction and psychomotor delay during infancy and later with supranuclear vertical gaze paresis, ataxia, marked spasticity, and dementia; (2) a delayed-onset, slowly progressive form heralded by the appearance, usually in early childhood, of mild intellectual impairment, supranuclear vertical gaze paresis, and ataxia, and later associated with dementia and, variably, seizures and extrapyramidal deficits; (3) a late-onset, slowly progressive form distinguished from the 2nd pattern by later age of onset (adolescence or adulthood) and a much slower rate of progression. The existence of the 1st and 2nd phenotypes within the same sibship suggests that they are variant expressions of the same clinicopathologic disorder. Niemann-Pick disease type C should be considered not only in infants and children who present with organomegaly and a progressive neurodegenerative course, but also in adolescents and adults who have insidiously progressive neurologic dysfunction and only slight organomegaly. Associated with the disease is a marked deficiency in the ability of cultured fibroblasts to esterify exogenously supplied cholesterol. Assay of this deficiency is particularly useful for confirming the diagnosis in patients with atypical presentation.

[1]  S. Patel,et al.  Type C Niemann-Pick disease. A parallel loss of regulatory responses in both the uptake and esterification of low density lipoprotein-derived cholesterol in cultured fibroblasts. , 1986, The Journal of biological chemistry.

[2]  S. Patel,et al.  Type C Niemann-Pick disease. Abnormal metabolism of low density lipoprotein in homozygous and heterozygous fibroblasts. , 1986, The Journal of biological chemistry.

[3]  R. Brady,et al.  A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Wenger,et al.  Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lysosomal storage diseases, including Niemann-Pick disease Type C. , 1985, Clinica chimica acta; international journal of clinical chemistry.

[5]  R. Rousson,et al.  Biochemical studies in Niemann‐Pick disease. III: In vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of the various forms of the disease , 1985, Clinical genetics.

[6]  A. Harder,et al.  Studies on lipids from liver and spleen of a child (O.L.) with Niemann-Pick's disease type C. , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[7]  N. Hudson,et al.  Sphingomyelinase in cultured skin fibroblasts from normal and Niemann‐Pick type C patients , 1983, Clinical genetics.

[8]  A. Ornoy,et al.  Clinical heterogeneity in a sibship with Niemann‐Pick disease type C , 1983, Clinical genetics.

[9]  M. Vanier Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. , 1983, Biochimica et biophysica acta.

[10]  J. Mazière,et al.  In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C. , 1982, Biochemical and biophysical research communications.

[11]  S. Roth,et al.  Acute neuronopathic (infantile) and chronic nonneuronopathic (adult) Gaucher disease in full siblings. , 1982, The Journal of pediatrics.

[12]  D. Cogan,et al.  Ocular motor signs in some metabolic diseases. , 1981, Archives of ophthalmology.

[13]  A. Poznanski,et al.  Mannosidosis: two brothers with different degrees of disease severity , 1981, Clinical genetics.

[14]  M. Vanier,et al.  Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease - development and evaluation of a microprocedure. , 1980, Clinica chimica acta; international journal of clinical chemistry.

[15]  R. Brady,et al.  A new form of Niemann-Pick disease characterised by temperature-labile sphingomyelinase. , 1978, Journal of medical genetics.

[16]  A. Koeppen,et al.  Supranuclear ophthalmoplegia in olivopontocerebellar degeneration , 1976, Neurology.

[17]  W. Grover,et al.  Progressive paresis of vertical gaze in lipid storage disease , 1971, Neurology.

[18]  A Ashkenazi,et al.  NIEMANN‐PICK DISEASE AND GIANT CELL TRANSFORMATION OF THE LIVER , 1971, Acta paediatrica Scandinavica.

[19]  G. Gopalakrishna,et al.  Niemann pick disease , 1970, Indian journal of pediatrics.

[20]  A. Tingey,et al.  The juvenile form of Niemann-Pick disease. , 1967, Archives of disease in childhood.

[21]  A. Crocker THE CEREBRAL DEFECT IN TAY‐SACHS DISEASE AND NIEMANN‐PICK DISEASE * , 1961, Journal of neurochemistry.

[22]  H. Kruth,et al.  Niemann-pick variant disorders: comparison of errors of cellular cholesterol homeostasis in group D and group C fibroblasts. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Cogan,et al.  The DAF syndrome , 1981 .

[24]  E. Eggermont,et al.  Niemann-Pick type C disease and early cholestasis in three brothers. , 1980, Acta paediatrica Belgica.

[25]  H. Christomanou Niemann-Pick disease, Type C: evidence for the deficiency of an activating factor stimulating sphingomyelin and glucocerebroside degradation. , 1980, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[26]  G. Pons,et al.  Maladie de surcharge neuro-viscérale avec ophtalmoplégie supra-nucléaire de la verticalité et présence dans la moelle d'histiocytes bleutés ou maladie de Neville. A propos de 2 observations. , 1976 .

[27]  I. B. Elfenbein Dystonic juvenile idiocy without amaurosis, a new syndrome. Light and electron microscopic observations of cerebrum. , 1968, The Johns Hopkins medical journal.